Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 31, Number 4—April 2025
Research
Carbapenem-Resistant, Virulence Plasmid–Harboring Klebsiella pneumoniae, United States
Table 1
Characteristics of case-patients in study of carbapenem-resistant, virulence plasmid–harboring Klebsiella pneumoniae isolates, United States*
Patient characteristic | Isolate |
|||||
---|---|---|---|---|---|---|
ARLG-4622 | ARLG-3254 | ARLG-4744 | ARLG-7683 | ARLG-3484 | ARLG-4720 | |
Location | Cleveland, OH | Houston, TX | Atlanta, GA | Atlanta, GA | Atlanta, GA | Atlanta, GA |
Hospital | Hospital A | Hospital B | Hospital C | Hospital C | Hospital C | Hospital C |
Department | Emergency department | Medical ward | Medical ward | Surgery ward | ICU | ICU |
Collection date |
2016 Jun |
2016 Sep |
2017 Jul |
2017 Oct |
2016 Dec |
2017 Mar |
Age group at culture, y | 39<49 | 49<59 | 49<59 | 59<69 | 69<79 | 49<59 |
Sex |
F |
M |
M |
M |
M |
M |
Hospital or community acquired | Hospital | Community | Hospital | Community | Hospital | Hospital |
Culture source | Urine | Respiratory | Urine | Wound | Respiratory | Respiratory |
Other pathogens from same source |
None |
None |
None |
None |
None |
None |
Infection vs. colonization |
Infection |
Infection |
Infection |
Colonization |
Colonization |
Colonization |
Charlson Comorbidity Index score | 0 | 3 | 4 | 1 | 8 | 1 |
Pitt bacteremia score |
0 |
3 |
8 |
2 |
6 |
4 |
DOOR outcomes | Alive without events | Dead | Dead | Alive without events | Alive with 2 or 3 events | Alive without events |
*DOOR, desirability of outcome ranking; ICU, intensive care unit.
Page created: February 18, 2025
Page updated: March 11, 2025
Page reviewed: March 11, 2025
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.